Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_assertion type Assertion NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_head.
- NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_assertion description "[In the human study, fasting levels of active GLP-1 were significantly lower in patients with coronary artery disease than those without (3.10 pmol/l [2.40 to 3.62 pmol/l] vs. 4.00 pmol/l [3.10 to 5.90 pmol/l], p < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_provenance.
- NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_assertion evidence source_evidence_literature NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_provenance.
- NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_assertion SIO_000772 22240132 NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_provenance.
- NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_assertion wasDerivedFrom befree-2016 NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_provenance.
- NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_assertion wasGeneratedBy ECO_0000203 NP952790.RATdliUd1fk3esp_BRZsmfm8t8R8emFAOTzMV1eHmuJ3w130_provenance.